Science News

... from universities, journals, and other research organizations

DNA Highly Promising Predictor For Successful Treatment Of Alcoholics

Oct. 5, 2006 — According to Dutch researcher Wendy Ooteman, the biological and genetic characteristics of alcoholics can predict which drugs will best suppress the desire to drink. Naltrexone and acamprosate are drugs that are supposed to suppress the desire for a drink. The researcher investigated which patient characteristics were responsible for predicting the drug that would work best.


Share This:

Alcoholics have an overwhelming urge to drink. That desire not only facilitates alcohol addiction but also ensures that the habit is difficult to kick. There are two drugs that can suppress this longing for alcohol: naltrexone works via the reward system in the brain and acamprosate via the stress system. However, they do not work for everybody. The question was whether patient characteristics can predict which drug works best for which patient.

Temptation

One hundred and fifty-six alcoholics were willing to participate in Ootemans' study. The participants’ desire to drink was aroused by, for example, placing a glass of their favourite drink on the table. Meanwhile they were posed questions about their urge for a drink and their physical reactions were measured, such as heart rate and sweat production. Genetic characteristics were also determined. After a month of treatment with naltrexone, acamprosate or a placebo the effect of clinical, physiological or genetic differences on the success of the treatment was examined.

Genetic indications

Clinical patient characteristics were found to be a poor predictor of whether someone would respond best to acamprosate or naltrexone. Biological and genetic characteristics could, however, predict this. People who started to sweat profusely during the experiment, responded better to acamprosate, whereas people who sweated less profusely responded better to naltrexone. Further genes which code for certain receptors in the brain predicted which drug would be successful for a patient. In particular, the genes that code for the mu-opioid receptor, the dopamine D2 receptor and a gaba receptor were found to be good predictors. This might be because these genes are closely associated with the causes of addiction.

Further research

The question is whether these same results will be found if longer term relapse is examined. It is expected that in particular the highly-promising genetic characteristics will be used for a more effective allocation of alcoholics to different treatments.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

|

Story Source:

The above story is reprinted from materials provided by Netherlands Organization for Scientific Research.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


APA

MLA

Note: If no author is given, the source is cited instead.

Search ScienceDaily

Number of stories in archives: 138,617

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.

Recommend ScienceDaily on Facebook, Twitter, and Google:

Other social bookmarking and sharing services:

|

 
Interested in ad-free access? If you'd like to read ScienceDaily without ads, let us know!
  more breaking science news

Social Networks


Follow ScienceDaily on Facebook, Twitter,
and Google:

Recommend ScienceDaily on Facebook, Twitter, and Google +1:

Other social bookmarking and sharing tools:

|

Breaking News

... from NewsDaily.com

  • more science news

In Other News ...

  • more top news

Science Video News


Pill To Fight Alcoholism

Neuropharmacologists ran clinical trials to find that a drug called topiramate is an effective therapeutic medication for decreasing heavy drinking. ...  > full story

Strange Science News

 

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?

Post this page to your favorite social bookmarking site:
Include this item in your blog or web site:
Cite this article in your essay, paper, or report:
Email this page's link to a friend or colleague: